Literature DB >> 34040229

Voclosporin improves outcomes in lupus nephritis.

Joanna Clarke1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34040229     DOI: 10.1038/s41584-021-00638-7

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

Authors:  Brad H Rovin; Y K Onno Teng; Ellen M Ginzler; Cristina Arriens; Dawn J Caster; Juanita Romero-Diaz; Keisha Gibson; Joshua Kaplan; Laura Lisk; Sandra Navarra; Samir V Parikh; Simrat Randhawa; Neil Solomons; Robert B Huizinga
Journal:  Lancet       Date:  2021-05-07       Impact factor: 79.321

  1 in total
  1 in total

Review 1.  Loss of Gut Barrier Integrity In Lupus.

Authors:  Longhuan Ma; Laurence Morel
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.